Heart failure (HF) substantially impacts the health and financial security of an increasing proportion of the US population. It worsens debility and quality of life and may lead to hospitalization and ...

Please provide your email address to receive an email when new articles are posted on . An AI-powered device to identify low left ventricular ejection fraction in patients at risk for HF gained 510(k) ...

August 12, 2011 — Older patients are more likely than younger patients with a similar low left ventricular ejection fraction to have cognitive decline, report researchers. "Cognitive dysfunction due ...

Based on pioneering research from Mayo Clinic, ECG-AI LEF aims to aid physicians in identifying low ejection fraction in patients at risk of heart failure CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading artificial intelligence (AI)-driven health technology company, announced that the Centers for Medicare & Medicaid Services (CMS) has included its ...

Credit: Eko Health. The FDA clearance was based on data from a prospective clinical study of 3456 patients. The Food and Drug Administration (FDA) has cleared the Eko Low Ejection Fraction Tool (ELEFT ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Dr. Butler answers the question: 'What Is An ACE Inhibitor?' — -- Question: What is an ACE inhibitor, how does it work, and when is it used to treat heart failure? Answer: ACE inhibitors are very ...

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of ...

The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...